Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

Clinical trial NCT00329745 · COMPLETED

Trial details

NCT number: NCT00329745
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Rotavirus

Start date: 2007-01-01
Primary completion: 2008-07-01
Enrollment: 8687

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.